Skip to content
Center for Reproductive Rights
Center for Reproductive Rights

Primary Menu

  • About
    • Overview
    • Center Leadership & Staff
    • Pro Bono Program
    • Creative Council
    • Annual Reports
    • Contact Us
    • Careers
    • Diversity, Equity and Inclusion
  • Work
    • Overview
    • Litigation
    • Legal Policy and Advocacy
    • Resources & Research
    • Recent Case Highlights
    • Landmark Cases
    • World’s Abortion Laws Map
    • After Roe Fell: Abortion Laws by State
  • Issues
    • Overview
    • Abortion
    • Adolescent Sexual and Reproductive Health and Rights
    • Assisted Reproduction
    • Contraception
    • Humanitarian Settings
    • Maternal Health
    • COVID-19
  • Regions
    • Overview
    • Africa
    • Asia
    • Europe
    • Latin America and the Caribbean
    • United States
    • Global Advocacy
  • News
    • Latest News
    • Center in the Spotlight
    • Events
    • Press Releases
    • Press Room
    • Newsletters
  • Resources
    • Resources & Research
    • World Abortion Laws Map
    • After Roe Fell: Abortion Laws by State
  • Act
    • Overview
    • Give
    • Act
    • Learn
  • Donate
    • Make a Gift Now
    • Be a Champion
    • Join the Advocates Council
    • Become a Major Donor
    • Give Through Your Donor-Advised Fund
    • Make a Gift In Honor
    • Attend an Event
    • Leave a Legacy
    • More Ways to Give
  • Twitter
  • Facebook
  • Instagram
  • YouTube
  • LinkedIn
Donate
icon-hamburger icon-magnifying-glass Donate
icon-magnifying-glass-teal

U.S. Repro Watch, Jan. 25

Center for Reproductive Rights - Center for Reproductive Rights - search logo
search Close Close icon
Center for Reproductive Rights -
Menu Close Menu Close icon
Donate

Primary Menu

  • About
    • Overview
    • Center Leadership & Staff
    • Pro Bono Program
    • Creative Council
    • Annual Reports
    • Contact Us
    • Careers
    • Diversity, Equity and Inclusion
  • Work
    • Overview
    • Litigation
    • Legal Policy and Advocacy
    • Resources & Research
    • Recent Case Highlights
    • Landmark Cases
    • World’s Abortion Laws Map
    • After Roe Fell: Abortion Laws by State
  • Issues
    • Overview
    • Abortion
    • Adolescent Sexual and Reproductive Health and Rights
    • Assisted Reproduction
    • Contraception
    • Humanitarian Settings
    • Maternal Health
    • COVID-19
  • Regions
    • Overview
    • Africa
    • Asia
    • Europe
    • Latin America and the Caribbean
    • United States
    • Global Advocacy
  • News
    • Latest News
    • Center in the Spotlight
    • Events
    • Press Releases
    • Press Room
    • Newsletters
  • Resources
    • Resources & Research
    • World Abortion Laws Map
    • After Roe Fell: Abortion Laws by State
  • Act
    • Overview
    • Give
    • Act
    • Learn
  • Donate
    • Make a Gift Now
    • Be a Champion
    • Join the Advocates Council
    • Become a Major Donor
    • Give Through Your Donor-Advised Fund
    • Make a Gift In Honor
    • Attend an Event
    • Leave a Legacy
    • More Ways to Give
  • Twitter
  • Facebook
  • Instagram
  • YouTube
  • LinkedIn

Related Content

Issues:

Abortion, SRHR General

Regions:

United States

Type:

US Repro Watch, News, Story

Follow the Center

Donate Now

Join Now

01.25.2023

Abortion United States News

U.S. Repro Watch, Jan. 25

Nat Ray
This week's top 4 news items on U.S. reproductive rights.

Share this Story

  • facebook
  • Twitter
  • linkedin
  • Email id

“U.S. Repro Watch” provides periodic updates on news of interest on U.S. reproductive rights. Here are four recent items you won’t want to miss:

1. Lawsuit threatening medication abortion: The Biden Administration urged a Texas court on January 13 to throw out the lawsuit against the FDA that could effectively ban medication abortion nationwide.

  • The case, filed by anti-abortion groups, seeks to revoke FDA approval of mifepristone, one of two drugs used in a medication abortion. If the court sides with anti-abortion groups, every state—including states where abortion is legal—will lose all access to medication abortion.
  • The FDA wrote that Americans would be “dramatically harmed” without access to mifepristone, “a safe and effective drug that has lawfully been on the market for twenty-two years.” A Maine abortion provider said that without mifepristone available, it would be forced to suspend abortion services at 17 of its 18 clinics across the largely rural state where care is already hard to access.
  • Medication abortion has been proven to be exceptionally safe and effective. It accounts for more than half (54%) of all abortions in the U.S. and is the preferred method for many patients.
  • “This should have been a fringe lawsuit, and it should have been tossed out very quickly,” said Senior Counsel Jenny Ma, commenting about the case in a New York Times article on various lawsuits involving medication abortion. “A single district court judge in Texas, which is a state that already has banned all abortion, could be issuing a nationwide ban on medication abortion, which now accounts for more than half of abortions in the United States, and obviously, the effects would be devastating,” added Ma.
  • Vanity Fair also reported on the Texas case, and The Cut and The Atlantic reported on the campaign against medication abortion.

More on abortion laws and policies in the states.

After Roe Fell: Abortion Laws by StateAfter Roe Fell: Abortion Laws by State link

After Roe Fell: Abortion Laws by State

Explore this interactive map to learn more about each state’s abortion laws and policies, updated in real time.

2. State legislators are continuing to push bills to both restrict and protect abortion.

  • The Minnesota House passed the Protect Reproductive Options (PRO) Act establishing a fundamental right to reproductive healthcare, including abortion, under state law. It now goes to the state Senate for consideration.
  • New Mexico Attorney General Raúl Torrez asked the state Supreme Court to block anti-abortion ordinances passed by local governments in the state. In a petition, the AG argued that the recent town ordinances restricting abortion access violate the state constitution.
  • Montana legislators are considering a bill that would explicitly clarify that the state constitution does not protect the right to abortion. The legislation seeks to challenge the Montana Supreme Court’s 1999 decision, which recognized state constitutional protections for abortion.
  • Wyoming lawmakers introduced legislation banning the use of abortion pills entirely.
  • The Florida Supreme Court rejected the Center and partners’ request to block a law banning abortion after 15 weeks of pregnancy. In a 4-1 decision, the court turned down a request to reverse the 1st District Court of Appeal’s ruling that allowed the law to stay in effect. The state Supreme Court also agreed to take up and hear the case; oral arguments have not yet been scheduled.

3. New York City unveiled plans to expand access to abortion and other reproductive health services.

  • New York would become the first U.S. city to offer free abortion pills at public health clinics.
  • Medication abortion is now available for free at a city-run health clinic in the Bronx. An additional three clinics across the city will offer the medication for free by the end of the year.
  • The city also aims to improve sexual health education and address inequities in maternal health.
  • The move is part of a $1.2 million package to expand access to health care.

Read more.

U.S. Repro Watch, Jan. 18U.S. Repro Watch, Jan. 18 link

U.S. Repro Watch, Jan. 18

Read last week’s U.S. Repro Watch.

4. January 22 marked the 50th anniversary of the Roe v. Wade decision.

  • President Joe Biden issued a proclamation on January 20 commemorating the Roe decision and called on Congress to pass legislation codifying the right to abortion into federal law.
  • Vice President Kamala Harris spoke about the anniversary in a speech in Florida on January 22.
  • Center President and CEO Nancy Northup was interviewed about Roe Day and discussed the legal battlefield.
  • Since the Supreme Court decision overturning Roe, abortion has become unavailable in 14 states.

Center in the Spotlight

Read select media coverage featuring Center leaders across the globe.

Did you know?

New research found that people living in states with abortion bans are three times more likely to die during pregnancy, childbirth, or soon after giving birth compared to those in states where abortion is accessible. Communities of color face even greater dangers. The maternal mortality rate is 4.5 times higher for Native American women and 2.6 times higher for Black women compared to their white counterparts.

Another study found that expanding Medicaid coverage for pregnant people could aid in reducing many of these preventable deaths. So far this year, eight states have introduced bills to extend postpartum Medicaid coverage to one year after childbirth.

Related Posts

Azar v. Garza Amicus Brief

Abortion,United States,In the Courts

Complaint: Falls Church Healthcare Center et al. v. Norman Oliver et al.

Abortion,United States,In the Courts

Amicus Brief: State of California et al. v. Alex M. Azar et al.

Other Barriers, Contraception,United States,In the Courts

Sign up for email updates.

The most up-to-date news on reproductive rights, delivered straight to you.

Footer Menu

  • Careers
  • Privacy Policy
  • Contact Us

Center for Reproductive Rights
© (1992-2022)

Use of this site signifies agreement with our disclaimer and privacy policy.

Center for Reproductive Rights
This site uses necessary, analytics and social media cookies to improve your experience and deliver targeted advertising. Click "Options" or click here to learn more and customize your cookie settings, otherwise please click "Accept" to proceed.
OPTIONSACCEPT
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
CookieDurationDescription
_ga2 yearsThis cookie is installed by Google Analytics. The cookie is used to calculate visitor, session, campaign data and keep track of site usage for the site's analytics report. The cookies store information anonymously and assign a randomly generated number to identify unique visitors.
_gat_UA-6619340-11 minuteNo description
_gid1 dayThis cookie is installed by Google Analytics. The cookie is used to store information of how visitors use a website and helps in creating an analytics report of how the wbsite is doing. The data collected including the number visitors, the source where they have come from, and the pages viisted in an anonymous form.
_parsely_session30 minutesThis cookie is used to track the behavior of a user within the current session.
HotJar: _hjAbsoluteSessionInProgress30 minutesNo description
HotJar: _hjFirstSeen30 minutesNo description
HotJar: _hjid1 yearThis cookie is set by Hotjar. This cookie is set when the customer first lands on a page with the Hotjar script. It is used to persist the random user ID, unique to that site on the browser. This ensures that behavior in subsequent visits to the same site will be attributed to the same user ID.
HotJar: _hjIncludedInPageviewSample2 minutesNo description
HotJar: _hjIncludedInSessionSample2 minutesNo description
HotJar: _hjTLDTestsessionNo description
SSCVER1 year 24 daysThe domain of this cookie is owned by Nielsen. The cookie is used for online advertising by creating user profile based on their preferences.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
CookieDurationDescription
_fbp3 monthsThis cookie is set by Facebook to deliver advertisement when they are on Facebook or a digital platform powered by Facebook advertising after visiting this website.
fr3 monthsThe cookie is set by Facebook to show relevant advertisments to the users and measure and improve the advertisements. The cookie also tracks the behavior of the user across the web on sites that have Facebook pixel or Facebook social plugin.
IDE1 year 24 daysUsed by Google DoubleClick and stores information about how the user uses the website and any other advertisement before visiting the website. This is used to present users with ads that are relevant to them according to the user profile.
IMRID1 year 24 daysThe domain of this cookie is owned by Nielsen. The cookie is used for storing the start and end of the user session for nielsen statistics. It helps in consumer profiling for online advertising.
personalization_id2 yearsThis cookie is set by twitter.com. It is used integrate the sharing features of this social media. It also stores information about how the user uses the website for tracking and targeting.
TDID1 yearThe cookie is set by CloudFare service to store a unique ID to identify a returning users device which then is used for targeted advertising.
test_cookie15 minutesThis cookie is set by doubleclick.net. The purpose of the cookie is to determine if the user's browser supports cookies.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
CookieDurationDescription
adEdition1 dayNo description
akaas_MSNBC10 daysNo description
cookielawinfo-checkbox-functional1 yearThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-others1 yearNo description
geoEdition1 dayNo description
next-i18next1 yearNo description
SAVE & ACCEPT
Powered by CookieYes Logo
Scroll Up